• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

CAR-T Cell Therapy Recipient Develops Rare Refractory Campylobacter Coli Infection

by
November 11, 2026
in Health
Reading Time: 2 mins read
0
CAR-T Cell Therapy Recipient Develops Rare Refractory Campylobacter Coli Infection

CAR-T Cell Therapy Recipient Develops Rare Refractory Campylobacter Coli Infection

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A case report published in BMC Infectious Diseases describes a middle-aged female with immune thrombocytopenia who developed refractory Campylobacter coli cellulitis accompanied by recurrent fever and severe hypogammaglobulinemia after undergoing chimeric antigen receptor T-cell therapy in a clinical trial.

Chimeric antigen receptor T-cell therapy has demonstrated efficacy in treating B-cell malignancies and autoimmune disorders, but on-target depletion of normal B cells through the targeting of CD19 or B-cell maturation antigen frequently produces secondary hypogammaglobulinemia. This targeted depletion substantially elevates the risk of opportunistic complications, though Campylobacter coli bloodstream infection presenting as persistent cellulitis has rarely been documented in this clinical setting.

Following chimeric antigen receptor T-cell infusion, the patient achieved complete remission of immune thrombocytopenia, maintaining a platelet count of 362 × 10⁹/L during the documented hospitalization. However, two months after the infusion, she presented with persistent bilateral lower limb cellulitis and recurrent fever that failed to respond over more than two months to multiple broad-spectrum antibiotic regimens, including levofloxacin, cefoperazone-sulbactam, and clindamycin.

An immunological evaluation revealed profound B-cell aplasia with 0 percent CD19-positive cells alongside severe pan-hypogammaglobulinemia, characterized by an immunoglobulin G level of 1.4 g/L, an immunoglobulin A level below 0.07 g/L, and an immunoglobulin M level below 0.004 g/L. Subsequent blood cultures identified the underlying pathogen as Campylobacter coli, an atypical bacterial agent that serves as an exceptionally rare cause of skin and soft tissue infection.

Resolution of the refractory infection was achieved through targeted administration of meropenem combined with intravenous immunoglobulin replacement therapy. During follow-up examinations, the patient exhibited complete clinical resolution, with total clearing of the bilateral lower extremity skin lesions and no recurrence of fever.

The reporting authors concluded that the case highlights the vulnerability of chimeric antigen receptor T-cell recipients with severe hypogammaglobulinemia to atypical extraintestinal Campylobacter infections. Based on these observations, they emphasized the necessity of prompt pathogen-directed diagnostics, dual antimicrobial and immunoglobulin replacement strategies, and the potential integration of routine immunoglobulin monitoring and intravenous immunoglobulin protocols into long-term post-therapy management.

Subject of Research: Refractory Campylobacter coli cellulitis and severe hypogammaglobulinemia following CAR-T cell therapy for immune thrombocytopenia

Article Title: Refractory Campylobacter coli cellulitis in severe hypogammaglobulinemia after CAR-T cell therapy for immune thrombocytopenia: a case report

Article References: Xiao, X., Zheng, X.-L., Cheng, Z., Zhou, H.-L., Huang, S.-W., & Hu, Q. (2026). Refractory Campylobacter coli cellulitis in severe hypogammaglobulinemia after CAR-T cell therapy for immune thrombocytopenia: a case report. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14371-7

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14371-7

Keywords: Campylobacter coli, cellulitis, CAR-T cell therapy, severe hypogammaglobulinemia, immune thrombocytopenia, B-cell aplasia, pan-hypogammaglobulinemia, intravenous immunoglobulin, meropenem, opportunistic infections, bloodstream infection, CD19, B-cell maturation antigen, levofloxacin, cefoperazone-sulbactam, clindamycin, platelet count, recurrent fever

News Source: Kristina Jarvis. (November 11, 2026). CAR-T Cell Therapy Recipient Develops Rare Refractory Campylobacter Coli Infection. Scienmag.

Tags: B-cell aplasiaB-cell maturation antigenbloodstream infectionCampylobacter coliCAR-T cell therapyCD19cefoperazone-sulbactamcellulitisclindamycinImmune thrombocytopeniaintravenous immunoglobulinlevofloxacinmeropenemopportunistic infectionspan-hypogammaglobulinemiaplatelet countrecurrent feversevere hypogammaglobulinemia
Share12Tweet7Share2ShareShareShare1

Related Posts

Cardiac Protein MYBPHL Rises to Protect Against Bacterial Sepsis Myocardial Injury

Cardiac Protein MYBPHL Rises to Protect Against Bacterial Sepsis Myocardial Injury

November 17, 2026
Community-Based Wheelchair Skills Training Shows Potential Cost-Effectiveness in Irish Study

Community-Based Wheelchair Skills Training Shows Potential Cost-Effectiveness in Irish Study

November 17, 2026

Nurse Referrals for Depression Rose While Clinic Counselling Adoption Lagged in KwaZulu-Natal

November 17, 2026

Clinicians report lower confidence and longer treatment times for transgender youth

November 17, 2026

POPULAR NEWS

  • Endometrial Receptivity During Embryo Implantation Linked to Endoplasmic Reticulum Stress

    Endometrial Receptivity During Embryo Implantation Linked to Endoplasmic Reticulum Stress

    29 shares
    Share 12 Tweet 7
  • Floral and Genetic Traits Differentiate Dwarf Succulent Species in South Africa

    29 shares
    Share 12 Tweet 7
  • Protocol Outlines Precise Chromosomal DNA Manipulations in Plants Using Programmable Recombinases

    29 shares
    Share 12 Tweet 7
  • Mild Respiratory Viruses Do Not Accelerate Biological Immune Aging After Recovery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cardiac Protein MYBPHL Rises to Protect Against Bacterial Sepsis Myocardial Injury

Shark Algorithm and Dynamic Modeling Optimize Four-Finger Cable Sorting Robot

Community-Based Wheelchair Skills Training Shows Potential Cost-Effectiveness in Irish Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.